Beryl Drugs Ltd is in the business of pharmaceuticals manufacturingBusiness Overview: BDL is mainly engaged in the domestic, institutions, and export supply of bulk drugs, pharmaceuticals, and healthcare products like I.V. Fluids and Small Volume Injectables. It manufactures and markets a range of branded, generic pharmaceutical formulations through its nationwide...
The company has published the notice for its 33rd Annual General Meeting. This meeting is a key event where shareholders are informed of the company's performance, strategic direction, and can vote on important matters, impacting the company's future operations and governance.
BERYL DRUGS has announced that shareholders can utilize remote e-voting for its upcoming 33rd Annual General Meeting on September 29th. The e-voting facility, provided via CDSL, allows eligible shareholders to cast their votes from September 26th (9:00 a.m. IST) until September 28th (5:00 p.m. IST). The cut-off date for determining...
Beryl Drugs Limited has set its 33rd Annual General Meeting for September 29 at 11:00 A.M. The company also announced a book closure period from September 23 to September 29 for the AGM. Shareholders' entitlement to vote via remote e-voting will be determined by a cut-off date of September 22....
